| P50 | author | Nina Clark | Q42642532 |
| | Jennifer E. Layden | Q106489149 |
| P2093 | author name string | Kimberly A Brown | |
| | Thomas J Layden | |
| | Scott Cotler | |
| | Helen S Te | |
| | Michael R Lucey | |
| | Sheila Eswaran | |
| | Claus Fimmel | |
| P2860 | cites work | Genetic variation in IL28B and spontaneous clearance of hepatitis C virus | Q24596340 |
| | Epidemiology of hepatitis C | Q28249543 |
| | Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance | Q28255243 |
| | Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study | Q28269827 |
| | Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C | Q29619541 |
| | The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 |
| | Donor race does not predict graft failure after liver transplantation | Q34007521 |
| | The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C | Q34398332 |
| | Hepatitis C infection in liver transplantation | Q34725183 |
| | Liver biopsy, viral kinetics, and the impact of viremia on severity of hepatitis C virus recurrence | Q35572066 |
| | Impact of donor and recipient race on survival after hepatitis C-related liver transplantation | Q35773603 |
| | Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with hepatitis C virus infection | Q37329869 |
| | A practical guide to the management of HCV infection following liver transplantation | Q37524390 |
| | HCV-related fibrosis progression following liver transplantation: increase in recent years | Q41732518 |
| | Racial differences in liver transplantation outcomes in the MELD era. | Q42649525 |
| | Effect of race on outcome of orthotopic liver transplantation: a cohort study | Q42669385 |
| | The association between hepatitis C infection and survival after orthotopic liver transplantation | Q42672810 |
| | Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients. | Q42822350 |
| | A comparison of the spectrum of chronic hepatitis C virus between Caucasians and African Americans | Q42985442 |
| | Predictors of patient and graft survival following liver transplantation for hepatitis C. | Q42989860 |
| | Long-term outcome of hepatitis C infection after liver transplantation | Q43046814 |
| | A model to predict severe HCV-related disease following liver transplantation. | Q43047851 |
| | The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation | Q43048437 |
| | Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. | Q43643377 |
| | Hepatitis C infection in African Americans: its natural history and histological progression | Q43939391 |
| | Factors differentially correlated with the outcome of liver transplantation in hcv+ and HCV- recipients | Q44956736 |
| | Relationship between the interleukin-28b gene polymorphism and the histological severity of hepatitis C virus-induced graft inflammation and the response to antiviral therapy after liver transplantation | Q45368415 |
| | Impact of donor and recipient IL28B rs12979860 genotypes on hepatitis C virus liver graft reinfection | Q45370605 |
| | Chronic hepatitis. An update on terminology and reporting. | Q53635198 |
| | Viral load 1 week after liver transplantation, donor age and rejections correlate with the outcome of recurrent hepatitis C | Q61054088 |
| | Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis | Q68071111 |
| | Impact of immunosuppression and acute rejection on recurrence of hepatitis C: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database | Q78078485 |
| | One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection | Q80582360 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 178-184 | |
| P577 | publication date | 2012-07-01 | |
| P1433 | published in | Transplantation | Q15730500 |
| P1476 | title | Racial differences in fibrosis progression after HCV-related liver transplantation | |
| P478 | volume | 94 | |